2018
DOI: 10.1136/thoraxjnl-2018-212634
|View full text |Cite
|
Sign up to set email alerts
|

Balancing fairness and efficacy in lung allocation for transplantation: unfinished business

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 14 publications
(9 reference statements)
0
2
0
Order By: Relevance
“…As is often the case in therapeutic endeavours where resource limitation (in this case donor availability) is a major factor, the clinical balance is how best to achieve the optimum result for the largest number of potential recipients. 46 The LAS works to maximize survival benefit but does not address modality specifically. Once the dominant form of LTx, heart-lung transplantation (HLTx) is now virtually reserved for congenital heart disease (CHD) refractory to medical and 6 journals.sagepub.com/home/tar surgical therapies and, in truth, is now rarely performed outside major high-volume centres.…”
Section: Which Transplant Modality?mentioning
confidence: 99%
See 1 more Smart Citation
“…As is often the case in therapeutic endeavours where resource limitation (in this case donor availability) is a major factor, the clinical balance is how best to achieve the optimum result for the largest number of potential recipients. 46 The LAS works to maximize survival benefit but does not address modality specifically. Once the dominant form of LTx, heart-lung transplantation (HLTx) is now virtually reserved for congenital heart disease (CHD) refractory to medical and 6 journals.sagepub.com/home/tar surgical therapies and, in truth, is now rarely performed outside major high-volume centres.…”
Section: Which Transplant Modality?mentioning
confidence: 99%
“…If the stated aim of LTx is to prolong life and improve quality of life of patients afflicted with terminal lung disorders, decisions regarding resource utilization must balance the needs of the individual patient with the needs of the community. 46 This ethical dilemma underscores many of the discussions regarding the use of SLTx versus BSSLTx, the use of extended criteria donors and recipient age criteria as well as the vexed question of retransplantation. 52 At extremes of age in particular, and, given the ravages of chronic diseases, it is important to consider actuarial survival as a factor when making decisions regarding suitability, allowing that ageism should not dictate behaviour.…”
Section: Resource Allocationmentioning
confidence: 99%